The clinical stage company involved in the development of disruptive therapeutics meant for addressing the urgent unmet medical needs of patients was in focus yesterday. Panbela Therapeutics Inc. (OTCQB: PBLA) saw its stock suffer from a selloff and record a decline of 7%. However, it should be noted that yesterday the company announced that it …
Continue reading “Panbela Therapeutics Inc. (OTCQB: PBLA) Stock Sees Sell-Off: Should You Panic?”